Matricelf Ltd
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 20… Read more
Matricelf Ltd (MTLF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -997.589x
Based on the latest financial reports, Matricelf Ltd (MTLF) has a cash flow conversion efficiency ratio of -997.589x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-8.28 Million) by net assets (ILA8.29K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Matricelf Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Matricelf Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Matricelf Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Matricelf Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MCDONALD'S HLDG
MU:MJ8
|
N/A |
|
FASTENAL - Dusseldorf Stock Exchang
DU:FAS
|
0.083x |
|
ProPhase Labs Inc
NASDAQ:PRPH
|
-3.137x |
|
SharonAI Holdings, Inc. Class A Common Stock
NASDAQ:SHAZ
|
-0.046x |
|
Canyon Creek Food Company Ltd
V:CYF
|
-0.009x |
|
CGGYD
PINK:CGGYD
|
0.074x |
|
Spearmint Resources Inc
PINK:SPMTF
|
-0.042x |
|
Direxion Daily AMD Bull 2X Shares
NASDAQ:AMUU
|
N/A |
Annual Cash Flow Conversion Efficiency for Matricelf Ltd (2019–2024)
The table below shows the annual cash flow conversion efficiency of Matricelf Ltd from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA15.17 Million | ILA-11.75K | -0.001x | -98.09% |
| 2023-12-31 | ILA26.80 Million | ILA-10.49K | 0.000x | +99.83% |
| 2022-12-31 | ILA35.79 Million | ILA-8.30 Million | -0.232x | +8.20% |
| 2021-12-31 | ILA26.23 Million | ILA-6.62 Million | -0.253x | +79.57% |
| 2020-12-31 | ILA2.80 Million | ILA-3.46 Million | -1.236x | -1354.61% |
| 2019-12-31 | ILA3.62 Million | ILA-307.80K | -0.085x | -- |